FDA Investigator Amber M Howell
Amber M Howell has conducted inspections on 32 sites in 1 countries as of 22 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
32
Last Inspection Date:
22 May 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Amber M Howell:
Aaron J Poloni,
Abby M Miller,
Alexander M Kay,
Amy R Glynn,
Avery J Dennis,
Barbara J Rincon,
Brenda K Alford,
Brian E Thompson,
Bruce R Burrell,
Bryce E Mansfield,
Ce'nedra M Martin,
Celia L Hutchinstein,
Christopher R Czajka,
Christopher S Genther,
Crystal A Harlan,
David J Gomes,
Debra D Devlieger,
Devon M Shoop,
Dirk L Lincoln,
Elizabeth A Sheller,
Elizabeth S Howell,
Gerard Pde Leon,
Gloria J Baca, MS,
Harmon M Blanch,
Heika R Tait,
Hugh A Grimoldby,
Ian J Thomson,
Jean Brewer,
Jeanne M Weishaar,
Jeff A Gard,
Jeffrey J Leclair,
Jeffrey N Gerdes,
Jessica B Clark,
Jinkee Mvila Binayug,
John E Emmert,
Jonathan T Little,
Jose O Caraballo Rivera,
Julia E Chervoni,
Julian C Hanson,
Kaitlyn R Kornberg,
Katherine L Arnold,
Keishla M Arroyo Lopez,
Kelsey A Hustedt,
Kelsey A Volkman,
Kimberly Jproctor Jones,
Leon R Marquart,
Leya A Grosch,
Lisa A Bowden,
Mai Hang,
Margo C Jones,
Mark E Imsland,
Mark E Moen,
Marsha L Mccauley,
Michael S Hudson,
Mikel T Wright,
Nancy E Byerly,
Nancy E Doyle,
Neil J Traaen,
Norman Fogg,
Paul F Rader,
Paula J Wilkerson,
Peter T Regan,
Rebecca A Sletner,
Rocco C Black,
Ronald E Gill,
Sandra K Wangen,
Scott A Nabe,
Shannon J Hall,
Shelagh D Schopen,
Sherri N Rohlf, MD,
Sonia R Peterson,
Stephanie A Jameson,
Stephen R Souza,
Tara A Marshall,
Tara M Pianko,
Thomas C Mclean, CFS,
Timothy S Williamson,
Vitaliy N Guyvan,
Wilfred J Omoloh,
Willis L Hicks,
Zachary P Wachlarowicz
Amber M Howell's Documents
Publish Date | Document Type | Title |
---|---|---|
July, 2018 | FDA 483 | Valley Processing, Inc. - Form 483, 2018-08-17 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more